Evolent Health, Inc. 4
4 · Evolent Health, Inc. · Filed May 23, 2017
Insider Transaction Report
Form 4
WIGGINTON STEVE
Chief Development Officer
Transactions
- Sale
Class A Common Stock
2017-05-19$24.30/sh−13,640$331,452→ 13,370 total
Footnotes (1)
- [F1]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.